Skip to menu Skip to content Skip to footer
Professor Gerald Holtmann
Professor

Gerald Holtmann

Email: 
Phone: 
+61 7 3176 7792

Overview

Background

Prof Holtmann is a Clinical Academic in the field of Gastroenterology & Hepatology and Director of Clinical Innovation. He is also Director of the Department of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and serves on the Board of Directors of the West Moreton Hospital and Health Service and UQ Healthcare. He is a Fellow of Royal Australian Collge of Physicians (RACP, Sydney), the Royal College of Physicians (RCP, London) and Fellow of the Australian Academy of Health and Medical Sciences (AAHMS, Canberra). Besides his Medical Qualifications he also obtained a Master of Business Administration. After completing the clinical training in Medicine and Gastroenterology at the University of Essen in Germany and the Mayo Clinic in Rochester, Minnesota in the United States, he has gained substantial leadership and managerial experience within the health care setting as Director of large Gastroenterology Departments, CEO and General Manager of a University Hospital and Health Care Facilities and has served on the Board of the University Hospital Essen in Germany. His research is in the field of Neurogastroenterology has resulted in peer reviewed publications in key journal including the NEJM, Lancet, Gastroenterology and Gut. More recently his rersearch focus is on the role of the gut microbiome, mucosal and systemic inflammation and brain-gut interactions.

Availability

Professor Gerald Holtmann is:
Available for supervision
Media expert

Works

Search Professor Gerald Holtmann’s works on UQ eSpace

539 works between 1986 and 2025

181 - 200 of 539 works

2019

Journal Article

An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy

Kutyla, Marguerite J., Shah, Ayesha, Elson, Jerome, Meeusen, Vera, O’Connor, Sam, Hourigan, Luke F. and Holtmann, Gerald J. (2019). An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy. Indian Journal of Gastroenterology, 38 (3), 268-272. doi: 10.1007/s12664-019-00966-3

An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy

2019

Conference Publication

In-vitro evaluation of antifoaming effects of simethicone: a dose-finding study

Kutyla, Marguerite, Shah, Ayesha, Meeusen, Vera, Elson, Jerome, Heulsen-Katz, Alex, Hourigan, Luke F. and Holtmann, Gerald J. (2019). In-vitro evaluation of antifoaming effects of simethicone: a dose-finding study. Digestive Disease Week (DDW), San Diego, CA United States, 18-21 May 2019. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.gie.2019.03.070

In-vitro evaluation of antifoaming effects of simethicone: a dose-finding study

2019

Conference Publication

Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R))

McMaster, Jessica J., Shanahan, Erin R., Anh Do,, Rich, Graeme, Veronique, Chachay, Macdonald, Graeme A. and Holtmann, Gerald J. (2019). Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R)). Digestive Disease Week (DDW), San Diego, CA USA, 18-21 May 2019. Philadelphia, PA USA: Elsevier.

Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R))

2019

Journal Article

Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress

Koloski, Natasha, Jones, Michael, Walker, Marjorie M., Veysey, Martin, Zala, Alkesh, Keely, Simon, Holtmann, Gerald and Talley, Nicholas J. (2019). Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Alimentary Pharmacology and Therapeutics, 49 (5), 546-555. doi: 10.1111/apt.15120

Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress

2019

Journal Article

Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

Shah, Ayesha, Morrison, Mark, Burger, Daniel, Martin, Neal, Rich, Justin, Jones, Mike, Koloski, Natasha, Walker, Marjorie M., Talley, Nicholas J. and Holtmann, Gerald J. (2019). Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 49 (6), 624-635. doi: 10.1111/apt.15133

Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

2019

Journal Article

The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences

Alammar, N., Wang, L., Saberi, B., Nanavati, J., Holtmann, G., Shinohara, R. T. and Mullin, G. E. (2019). The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences. BMC Complementary and Alternative Medicine, 19 (1) 21, 21. doi: 10.1186/s12906-018-2409-0

The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences

2019

Book Chapter

Clinical conditions associated with bacterial overgrowth

Shah, Ayesha and Holtmann, Gerald (2019). Clinical conditions associated with bacterial overgrowth. Gastrointestinal diseases and their associated infections. (pp. 67-83) edited by Guy D. Eslick. St. Louis, MO, United States: Elsevier. doi: 10.1016/B978-0-323-54843-4.00006-4

Clinical conditions associated with bacterial overgrowth

2019

Journal Article

Immune activation in functional gastrointestinal disorders

Burns, Grace, Pryor, Jennifer, Holtmann, Gerald, Walker, Marjorie M., Talley, Nicholas J. and Keely, Simon (2019). Immune activation in functional gastrointestinal disorders. Gastroenterology and Hepatology, 15 (10), 539-548.

Immune activation in functional gastrointestinal disorders

2019

Journal Article

Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches

Holtmann, Gerald, Schrenk, Dietmar, Madisch, Ahmed, Allescher, Hans D., Ulrich-Merzenich, Gudrun, Mearin, Fermin, Larrey, Dominique and Malfertheiner, Peter (2019). Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches. Digestive Diseases, 38 (4), 1-11. doi: 10.1159/000504570

Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches

2019

Conference Publication

273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study

Bray, Nicola, Koloski, Natasha A., Jones, Michael P., Do, Anh, Talley, Nicholas J., McAllister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Che-yung, Billin, Abi, Bettens, Gemma, Catague, Rachel, Whaley, Amanda, Macdonald, Graeme A. and Holtmann, Gerald J. (2019). 273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study. Digestive Disease Week 2019, San Diego, CA, United States, 18-21 May 2019. PHILADELPHIA: Elsevier BV. doi: 10.1016/s0016-5085(19)36917-3

273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study

2019

Journal Article

Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis

Shah, Ayesha, Crawford, Darrel, Burger, Daniel, Martin, Neal, Walker, Marjorie, Talley, Nicholas J., Tallis, Caroline, Jones, Michael, Stuart, Katherine, Keely, Simon, Lewindon, Peter, MacDonald, Graeme A., Morrison, Mark and Holtmann, Gerald J. (2019). Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis. Seminars in Liver Disease, 39 (4), 432-441. doi: 10.1055/s-0039-1688501

Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis

2019

Conference Publication

Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms

Bray, Nicola, Koloski, Natasha A., Jones, Michael P., Do, Anh, Talley, Nicholas J., Billin, Abi, Bettens, Gemma, McAllister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Che-Yung, Catague, Rachel, Whaley, Amanda, Macdonald, Graeme A. and Holtmann, Gerald (2019). Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms. Digestive Disease Week, San Diego, CA, United States, 18-21 May, 2019. PHILADELPHIA: Elsevier BV. doi: 10.1016/s0016-5085(19)39623-4

Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms

2019

Conference Publication

Factorial analysis-based assessment of the Mucosa Associated Microbiome

Holtmann, Gerald, Morrison, Mark, Talley, Nicholas, Koloski, Natasha, Shah, Ayesha and Jones, Michael (2019). Factorial analysis-based assessment of the Mucosa Associated Microbiome. Asia Pacific Digestive Week, Kolkata, India, 12–15 December 2019. Hoboken, NJ United States: Wiley.

Factorial analysis-based assessment of the Mucosa Associated Microbiome

2018

Journal Article

Gastroduodenal "Dysbiosis": a new clinical entity

Shah, Ayesha, Morrison, Mark and Holtmann, Gerald J. (2018). Gastroduodenal "Dysbiosis": a new clinical entity. Current Treatment Options in Gastroenterology, 16 (4), 591-604. doi: 10.1007/s11938-018-0207-x

Gastroduodenal "Dysbiosis": a new clinical entity

2018

Conference Publication

Quantitative PCR as a novel approach to determine influence of density of bacterial colonization on health and disease

Shah, Ayesha, Shanahan, Erin, Berendsen, Erwin, Macdonald, Graeme, Rich, Justin, Ghasemi, Pegah, Hansen, Teressa, Koloski, Natasha, Burger, Daniel, Keeley, Simon, Walker, Marjorie, Talley, Nicholas, Morrison, Mark and Holtmann, Gerald (2018). Quantitative PCR as a novel approach to determine influence of density of bacterial colonization on health and disease. Asian Pacific Digestive Week (APDW). Connecting Excellence on Gastroenterology and Hepatology in Asia-Pacific, Seoul, Korea, 15–18 November 2018. Richmond, VIC, Australia: Wiley-Blackwell.

Quantitative PCR as a novel approach to determine influence of density of bacterial colonization on health and disease

2018

Conference Publication

Systematic review and meta-analysis: Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome

Shah, Ayesha, Talley, Nicholas J., Rich, Justin, Ghasemi, Pegah, Jones, Mike, Kendall, Bradley J., Burger, Daniel, Koloski, Natasha, Walker, Marjorie, Morrison, Mark and Holtmann, Gerald (2018). Systematic review and meta-analysis: Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome. Asian Pacific Digestive Week (APDW), Seoul, Korea, 15–18 November 2018. Hoboken, NJ, United States: Wiley-Blackwell.

Systematic review and meta-analysis: Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome

2018

Conference Publication

Systematic review of the use of oral antibiotic therapy in primary sclerosing cholangitis and inflammatory bowel disease

Shah, Ayesha, Burger, Daniel, Stuart, Katherine, Martin, Neal, Walker, Marjorie, Tallis, Caroline, Jones, Mike, Macdonald, Graeme, Talley, Nicholas, Morrison, Mark and Holtmann, Gerald (2018). Systematic review of the use of oral antibiotic therapy in primary sclerosing cholangitis and inflammatory bowel disease. Asian Pacific Digestive Week (APDW). Connecting Excellence on Gastroenterology and Hepatology in Asia-Pacific, Seoul, Korea, 15–18 November 2018. Richmond, VIC, Australia: Wiley-Blackwell.

Systematic review of the use of oral antibiotic therapy in primary sclerosing cholangitis and inflammatory bowel disease

2018

Conference Publication

Zonulin as a Biomarker to Identify the Irritable Bowel Syndrome (IBS), Functional Dyspepsia (FD), and Non-Celiac Wheat Sensitivity (NCWS)

Talley, Nicholas J., Holtmann, Gerald, Walker, Marjorie M., Jones, Michael, Koloski, Natasha A. and Keely, Simon (2018). Zonulin as a Biomarker to Identify the Irritable Bowel Syndrome (IBS), Functional Dyspepsia (FD), and Non-Celiac Wheat Sensitivity (NCWS). Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Philadelphia, PA, United States, 5-10 October 2018. Philadelphia, PA, United States: Wolters Kluwer Health.

Zonulin as a Biomarker to Identify the Irritable Bowel Syndrome (IBS), Functional Dyspepsia (FD), and Non-Celiac Wheat Sensitivity (NCWS)

2018

Conference Publication

Anti-Cytolethal Distending Toxin B Antibody (Anti-CdtB) Differentiates Functional Dyspepsia From Healthy Controls

Talley, Nicholas J., Holtmann, Gerald, Walker, Marjorie M., Jones, Michael, Koloski, Natasha A. and Keely, Simon (2018). Anti-Cytolethal Distending Toxin B Antibody (Anti-CdtB) Differentiates Functional Dyspepsia From Healthy Controls. Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Philadelphia, PA, United States, 5-10 October 2018. Philadelphia, PA, United States: Wolters Kluwer Health.

Anti-Cytolethal Distending Toxin B Antibody (Anti-CdtB) Differentiates Functional Dyspepsia From Healthy Controls

2018

Conference Publication

Quantitative polymerase chain reaction as a novel approach to determine influence of density of bacterial colonization on health and disease

Shah, A., Shanahan, E., Berendsen, E., Macdonald, G., Rich, J., Ghasemi, P., Hansen, T., Koloski, N., Burger, D., Keely, S., Walker, M., Talley, N. J., Morrison, M. and Holtmann, G. (2018). Quantitative polymerase chain reaction as a novel approach to determine influence of density of bacterial colonization on health and disease. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “Gut Matters”, Brisbane, QLD Australia, 8-10 September 2018. Richmond, VIC Australia: John Wiley & Sons.

Quantitative polymerase chain reaction as a novel approach to determine influence of density of bacterial colonization on health and disease

Funding

Current funding

  • 2022 - 2026
    ARC Training Centre for Behavioural Insights for Technology Adoption (BITA) (ARC Industrial Transformation Training Centre Administered by QUT)
    Queensland University of Technology
    Open grant
  • 2021 - 2025
    A practice change for patients with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled intervention to assess efficacy and cost-effectiveness
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2014 - 2017
    Functional dyspepsia: Characterisation of the immunopathology and testing a novel therapeutic strategy (NHMRC Project Grant administered by the University of Newcastle)
    University of Newcastle
    Open grant

Supervision

Availability

Professor Gerald Holtmann is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    IBD and mental health tools: a holistic approach to discovery and appropriate tool.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Reimagining Health Equity and Access in Colorectal Cancer Screening. A population perspective.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Exercise training on people with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled trial.

    Associate Advisor

    Other advisors: Professor Jeff Coombes

  • Doctor Philosophy

    The role of the gut microbiome in alcohol related liver disease

    Associate Advisor

    Other advisors: Professor Jason Connor, Dr Paul Clark

  • Doctor Philosophy

    Study of TOfacitinib for the treatment of chronic Pouchitis

    Associate Advisor

    Other advisors: Associate Professor Jakob Begun

Completed supervision

Media

Enquiries

Contact Professor Gerald Holtmann directly for media enquiries about:

  • colon cancer screening
  • Gastroenterology
  • Gut Health
  • Microbiome
  • Neurogastroenterology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au